Infliximab-induced remission of extensive plaque psoriasis.
Amital
Howard
H
Rheumatology Unit, Division of Internal Medicine, Hadassah University Hospital, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Ingber
Arieh
A
Rubinow
Alan
A
D000284:Administration, Oral; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D007275:Injections, Intravenous; D008727:Methotrexate / Q000008:administration & dosage; D011565:Psoriasis / Q000188:drug therapy*; D012074:Remission Induction; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab; D008727:Methotrexate